FOXO3 and breast cancer: Additionally, in breast cancer cells with acquired epirubicin resistance, SIRT 4, 5, 6 and 7 were found to be upregulated, particularly SIRT6, which has been shown to induce epirubicin resistance by mediating the deacetylation and inhibition of FOXO3 [52].